Actively Recruiting
Breast Cancer Implementation Science Study With Educational Intervention
Led by NYU Langone Health · Updated on 2026-03-30
30
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
D
Daiichi Sankyo
Collaborating Sponsor
AI-Summary
What this Trial Is About
A study uniquely focused on system-based practice change, measuring the impact of educational interventions on both patients and clinicians for the recognition and management of treatment-related adverse effects for HER2+/HER2 low breast cancer patients on or about to start on HER2 targeted antibody drug conjugates (fam-trastuzumab deruxtecan-nxki or ado-trastuzumab emtansine) and shared decision-making methodologies to improve adverse event (AE) management and patient-clinician communications.
CONDITIONS
Official Title
Breast Cancer Implementation Science Study With Educational Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Confirmed diagnosis of HER2-positive or HER2-low breast cancer
- Receiving or about to receive HER2-targeted antibody drug conjugates (ADCs)
- Able to sign informed consent and comply with study requirements including 3 visits (can be virtual), surveys, training, interviews, and focus groups
- Able to read, speak, and understand English
- Access to or ability to use a computer or iPad with internet for data entry and training
- Clinicians must be physicians, nurse practitioners, physician assistants, nurses, or pharmacists working with HER2-positive or HER2-low breast cancer patients
- Clinicians must agree to see their own patients during study visits to reduce variability
- Clinicians must be willing to participate in protocol requirements including interviews, role plays, patient visits, and virtual training videos
You will not qualify if you...
- History of noncompliance
- Inability to attend required visits (in-person or virtual)
- Inability to participate in training
- Non-ambulatory status
- Limiting comorbidities such as psychiatric diagnosis or significant cognitive impairment
- Pregnant patients
- No internet or computer access
- Clinicians unable to participate in required virtual visits, training, assessments, or protocol requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
L
Lucia Greco
CONTACT
N
Nadia Chowdhury
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here